Bosentan is a dual endothelin receptor antagonist used in the treatment of
pulmonary artery hypertension (PAH). It is licensed in the United States, the
What is Tracleer<sup>®</sup> (bosentan)?. Tracleer is a prescription medicine indicated for
patients with certain types of pulmonary arterial hypertension (PAH, WHO Group
Easy to read patient leaflet for bosentan. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Jul 15, 2016 ... Bosentan: learn about side effects, dosage, special precautions, and more on
Learn about Tracleer (Bosentan) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related medications.
Medscape - Indication-specific dosing for Tracleer (bosentan), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Consumer information about the medication BOSENTAN - ORAL (Tracleer),
includes side effects, drug interactions, recommended dosages, and storage ...
Jun 13, 2005 ... Bosentan is metabolized in the liver by the cytochrome P450 enzymes CYP2C9
and CYP3A4 (and possibly CYP2C19), producing three ...
Find patient medical information for bosentan oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Jan 11, 2017 ... Pulmonary arterial hypertension (PAH) can be treated by Bosentan tablets such
as Tracleer. More about Bosentan tablets.